-+ 0.00%
-+ 0.00%
-+ 0.00%

PMV PHARMACEUTICALS, - PLANS NDA SUBMISSION FOR ACCELERATED APPROVAL OF REZATAPOPT IN Q1 2027

Reuters·10/05/2026 12:00:03

Please log in to view news